Kangio (bivalirudin) Injection Trademark Details

This mark is dead with a status of Abandoned - After Publication. The last case file activity for this mark occured 7 years ago on Thursday, August 4, 2016, according to the United State Patent & Trademark Office
Word Mark Kangio (Bivalirudin) Injection
Status Dead 605 — Abandoned - After Publication

Current Owner

Eagle Pharmaceuticals, Inc. of Woodcliff Lake, NJ

View all trademarks for Eagle Pharmaceuticals, Inc.
Other Trademarks for Eagle Pharmaceuticals, Inc.
Serial Number 86851053
Status Date Thursday, August 4, 2016
Filing Date Thursday, August 4, 2016
Attorney Michelle Elizabeth Legiec

Correspondent

MICHELLE ELIZABETH LEGIEC
50 TICE BOULEVARD, SUITE 315
WOODCLIFF LAKE, NJ 07677

Case File Statements

Disclaimer with Predetermined Text "Bivalirudin Injection"
Goods & Services Bivalirudin Preparations for Pharmaceutical Purposes

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 8 — Abandoned
Status Date Thursday, August 4, 2016
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.